PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close
LK Chem is a specialty chemical materials maker whose core revenue comes from semiconductor thin-film deposition precursors and ligands, and after a 2025 industry slowdown, earnings showed a recovery in the first half of 2026 on a large supply contract.
Although classified under the secondary battery theme on KOSDAQ, the company's core revenue driver is semiconductor ALD precursors and ligands, with the battery-related product (metal extractant) being just one diversification line.
Annual revenue fell to KRW 20.18 billion in 2025 from KRW 25.04 billion in 2024, with operating margin dropping from 40.5% to 22.6%, before a recovery trend emerged in H1 2026 on a large DIS single supply contract.
The company is pursuing domestic production of HfCl4, the raw material for hafnium precursor (CP-Hf), ahead of the expiration of a related Japanese Tri Chemical Laboratories patent in November 2026.
The company holds roughly a 21.9% share of the domestic CP ligand market, while PCP ligand and DIS precursor are reported to be supplied domestically on an exclusive basis.
As a small-cap stock listed on KOSDAQ in February 2025, market capitalization is small, which can mean greater liquidity constraints and price volatility.
LK Chem, established in 2007 and listed on KOSDAQ on February 25, 2025, is a specialty chemical materials company focused on semiconductor thin-film deposition processes.
Its core products are CP and PCP ligands used for High-k dielectric film formation and DIS precursor used for Low-k film formation in the atomic layer deposition (ALD) process, and as of 2023 revenue mix by product was reported at 68.5% High-k, 12.1% Low-k, 2.0% other materials, and 17.4% other (merchandise, etc.).
CP and PCP ligands serve as key raw materials for synthesizing various High-k precursors, while DIS precursor is used to form uniform nitride films on wafer surfaces in system semiconductor and 3D NAND flash processes.
More recently the company has expanded its lineup with new High-k products such as molybdenum precursor and yttrium ligand, raising their share of revenue.
In other specialty chemical areas, the company produces perovskite solar cell photovoltaic materials and charge transport layer materials, purification solvents for carbon capture, metal extractants for secondary battery recycling, and inorganic metal materials for displays, pursuing business diversification.
Although the company is grouped under the secondary battery theme in KOSDAQ sector classification, its actual revenue contribution is overwhelmingly from semiconductor materials, with battery-related products constituting only a small new-business line.
The company is understood to supply materials to large semiconductor manufacturers, and industry sources note that because material switching in semiconductor processes requires years of qualification, once a supplier is adopted it tends to maintain a long-term relationship.
In the competitive landscape, overseas firms, notably from Japan, have long held source technology for precursors, but the company appears to be expanding its footprint as a domestic supplier amid growing demand for localization.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩5.8B | ₩1.7B | 30.3% |
| 2025Q3 | ₩5.6B | ₩1.6B | 28.0% |
| 2025Q4 | ₩5.5B | ₩800M | 14.4% |
| 2026Q1 | ₩6.1B | ₩1.1B | 18.3% |
| 2026Q2 | ₩7.6B | ₩1.9B | 24.9% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2023 | ₩15.3B | ₩5.6B | ₩3.4B | 36.8% | 28.9% | 178.9% |
| 2024 | ₩25B | ₩10.1B | ₩6.8B | 40.5% | 19.9% | 19.7% |
| 2025 | ₩20.2B | ₩4.6B | ₩4.4B | 22.6% | 7.3% | 11.0% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-05
Annual revenue in 2024 reached KRW 25.04 billion with operating profit of KRW 10.14 billion (40.5% operating margin) and owners' net income of KRW 6.85 billion, marking substantial top-line and profit growth versus 2023 (revenue KRW 15.26 billion, operating profit KRW 5.61 billion, net income KRW 3.38 billion).
However, in 2025 revenue declined to KRW 20.18 billion and operating profit fell to KRW 4.57 billion (22.6% margin), a sharp margin contraction from the prior year, while owners' net income also dropped to KRW 4.35 billion.
According to FnGuide data, the nine-month cumulative figures through Q3 2025 showed year-on-year declines of 25.9% in revenue, 57.4% in operating profit, and 37.7% in net income, suggesting a semiconductor industry slowdown was the main driver of the earnings weakness.
On a quarterly basis, revenue and profit moderated gradually from KRW 5.76 billion revenue and KRW 1.75 billion operating profit in Q2 2025, to KRW 5.56 billion/KRW 1.56 billion in Q3, and KRW 5.49 billion/KRW 0.79 billion in Q4.
The trend then turned upward, with Q1 2026 revenue of KRW 6.06 billion and operating profit of KRW 1.11 billion, followed by a marked improvement in Q2 2026 to revenue of KRW 7.64 billion, operating profit of KRW 1.90 billion, and owners' net income of KRW 1.87 billion.
The company attributed the improvement to volume from a roughly KRW 21.2 billion DIS single supply contract signed in May being fully reflected in Q2 results, related to nitride film-forming materials for system semiconductor and 3D NAND flash applications.
Combined owners' net income over the most recent four quarters (Q3 2025-Q2 2026) totals about KRW 6.08 billion, which can be read as a phase of profit expansion following a trough in Q4 2025.
Whether the elevated 2024 margin reflected a one-off factor or a structural driver will require further confirmation through upcoming quarterly results.
The semiconductor precursor materials market that LK Chem operates in is structurally supported by rising demand for ultra-high-purity deposition materials as chip miniaturization advances.
At the time of its IPO, Eugene Investment & Securities projected the global semiconductor precursor market would grow at a compound annual rate of 14.8% from 2023 to 2028.
According to NH Investment & Securities, as AI chip efficiency becomes a greater focus, demand for ultra-high-purity materials for sub-2-nanometer processes is rising, and the company is understood to hold roughly a 21.9% share of the domestic CP ligand market, with PCP ligand and DIS precursor supplied domestically on an exclusive basis.
However, the semiconductor market is characterized by repeated boom-bust cycles, and fluctuations in utilization rates and output at integrated device manufacturers directly affect material demand, which has been cited as the backdrop for the 2025 earnings weakness.
In terms of competition, overseas firms such as Japan's Tri Chemical Laboratories have long held source patents related to hafnium precursor (CP-Hf), but with that patent set to expire in November 2026, the industry expects a shift toward a more competitive supply structure and intensified cost competition.
Repeated global supply chain disruptions have also prompted domestic semiconductor customers to seek secure domestic supply chains for strategic materials, which is cited as a favorable backdrop for LK Chem's localization efforts.
That said, entering the supply chain as a new vendor typically requires years of testing and trust-building, meaning incumbent suppliers tend to retain a relatively stable position.
The company has stated its policy of securing a stable growth foundation in the second half of 2026 by expanding DIS precursor supply, which drove the H1 2026 earnings improvement, along with growing sales of new products such as molybdenum precursor and yttrium ligand.
NH Investment & Securities noted that the company expanded DIS production facilities to secure roughly KRW 60 billion in production capacity, is already applying the material to a specific 5-nanometer process through an existing customer, and is conducting tests with additional customers.
In the medium term, the company is pursuing full-process domestic production of HfCl4, the core raw material for hafnium-based precursors that had previously been entirely imported, dividing the process into four stages (extraction/separation, chlorination, high-purity purification, and precursor synthesis) in collaboration with domestic research institutes and companies, with a targeted commercial sales launch in 2027.
This timeline coincides with the expiration of Japan's Tri Chemical Laboratories patent related to CP-Hf on November 28, 2026, making the market entry of the localized material after patent expiration a key point to watch.
Over the longer term, the company plans to expand into the solar sector through development of core perovskite solar cell precursors and charge transport layer materials, while continuing to broaden its product lineup with high-value materials such as cobalt, molybdenum, and yttrium.
CEO Lee Chang-yeob has stated the company's aim to strengthen its existing semiconductor materials business while pursuing next-generation material development and customer diversification to secure a stable growth base.
It is worth noting that current valuation metrics are being formed at a point where the company is moving through a profit recovery phase in H1 2026 following the 2025 earnings contraction.
Given that the IPO offering price was set at a discount to a peer-average PER of 23.4x (applied to trailing four-quarter earnings as of Q3 2024), the multiple at which shares currently trade can be viewed against that reference point.
In terms of price-to-book, the stock carries a certain premium over net asset value, which can be interpreted as reflecting some market expectation around semiconductor material localization and the new-business pipeline.
On the dividend side, no per-share cash dividend has been confirmed in recent disclosures, placing this stock in a category where the earnings growth trajectory matters more than dividend appeal.
That said, it should also be considered that, as seen in 2025, earnings volatility during semiconductor industry downcycles can directly feed through into valuation.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-05
Volume from a roughly KRW 21.2 billion DIS single supply contract signed in May 2026 was fully reflected in Q2 results, driving a clear improvement in revenue and profit.
Quarter-on-quarter, revenue rose from KRW 6.06 billion in Q1 2026 to KRW 7.64 billion in Q2, and operating profit rose from KRW 1.11 billion to KRW 1.90 billion. Testing with additional customers (referred to as companies I and M) is ongoing, leaving room for further supply expansion.
According to NH Investment & Securities, LK Chem holds roughly a 21.9% share of the domestic CP ligand market, and PCP ligand and DIS precursor are reportedly supplied domestically on an exclusive basis.
Given that material switching in semiconductor processes requires years of qualification, once a supplier is adopted it tends to maintain a long relationship, which is also cited as a strength.
The company is pursuing domestic production of HfCl4, the key raw material, timed to the November 2026 expiration of Japan's Tri Chemical Laboratories CP-Hf-related patent, targeting a 2027 sales launch.
It is also developing a range of new business lines including perovskite solar cell materials, carbon capture solvents, and secondary battery recycling metal extractants, diversifying its medium- to long-term growth drivers.
Annual revenue fell to KRW 20.18 billion in 2025 from KRW 25.04 billion in 2024, and operating margin declined from 40.5% to 22.6%.
According to FnGuide, cumulative revenue, operating profit, and net income all fell by double digits year-on-year through Q3 2025, illustrating how directly results are affected by fluctuations in integrated device manufacturers' utilization rates and output.
When Japan's Tri Chemical Laboratories CP-Hf-related patent expires in November 2026, the existing exclusive supply structure could shift toward greater competition, which represents both a localization opportunity for LK Chem and a factor that could also increase market entry by other competitors.
Commercial sales of the localized material are targeted for 2027, meaning there is a time lag before any actual revenue contribution.
As a small-cap listed in February 2025 with modest market capitalization, price volatility can increase when trading volume is thin.
Because mandatory holding periods on certain major shareholder stakes are structured to be released in stages, future changes in free float are also cited as a variable that could affect share price behavior.
Demand for semiconductor materials is directly tied to the utilization rates and output of integrated device manufacturers, so a downturn like the one seen in 2025 can cause a sharp contraction in results.
Revenue is presumed to be concentrated among a small number of large customers, meaning order changes from a specific customer can materially affect performance.
The core initiative to localize hafnium precursor production is premised on the expiration of Japan's Tri Chemical Laboratories patent in November 2026, so any delay in patent expiration or in localization technology development could disrupt the targeted 2027 sales launch.
In addition, competitors are also pursuing the same opportunity, making maintaining a technological edge critical.
There are governance-related conditions such as a mandatory holding period of two years and six months on the largest shareholder's stake after listing, and free float could change depending on the timing of future lock-up releases.
Given its small market capitalization, share price volatility could widen in the event of shifts in institutional demand or a sharp drop in trading volume.
This is the expiration date of Japan's Tri Chemical Laboratories source patent related to CP-Hf; it will be important to check how LK Chem's localized material addresses market entry after expiration.
Q3 2026 results are expected to be disclosed around this time; it will be worth checking whether the profit recovery trend seen in Q2 continues.
This is the point to check the outcome of DIS supply testing with new customers (referred to as companies I and M) mentioned by NH Investment & Securities, and whether actual supply begins.
This is the targeted timing for the commercial sales launch of domestically produced HfCl4, the core raw material for hafnium-based precursors; it will need to be confirmed whether this proceeds as planned.
LK Chem is classified under the secondary battery theme in KOSDAQ sector classification, but its business is actually centered on precursors and ligands for semiconductor thin-film deposition, with secondary battery-related products constituting only a small part of its diversification lineup.
After strong growth and margins in 2024, revenue and operating margin declined sharply in 2025 amid a semiconductor industry slowdown, but H1 2026 showed a recovery in quarterly results as a large DIS supply contract was reflected.
The hafnium precursor localization effort and pipeline of new businesses such as perovskite materials are cited as medium- to long-term growth drivers, but there is a time lag before these translate into actual revenue, extending into 2027 and beyond.
The company's market share and supply stability in the domestic CP, PCP, and DIS materials markets are cited as strengths, while sensitivity to the semiconductor cycle and the liquidity volatility typical of a small-cap stock are factors that should also be weighed.
Going forward, the competitive landscape shift after the November 2026 CP-Hf patent expiration, Q3 results, and progress in new customer supply expansion are likely to be key points to monitor.
This report is prepared for informational purposes to support investment judgment and does not contain a buy or sell recommendation.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.